相似文献
1
Profibrotic pathways and atrial cardiomyopathy in persistent atrial fibrillation.
Clinics (Sao Paulo). 2016 Oct 1;71(10):626. doi: 10.6061/clinics/2016(10)12.
2
3
Concomitant ablation for atrial fibrillation during septal myectomy in patients with hypertrophic obstructive cardiomyopathy.
J Thorac Cardiovasc Surg. 2018 Apr;155(4):1536-1542.e2. doi: 10.1016/j.jtcvs.2017.08.063. Epub 2017 Sep 1.
4
Does ablation of atrial fibrillation at the time of septal myectomy improve survival of patients with obstructive hypertrophic cardiomyopathy?
J Thorac Cardiovasc Surg. 2021 Mar;161(3):997-1006.e3. doi: 10.1016/j.jtcvs.2020.08.066. Epub 2020 Aug 25.
5
Catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy.
Heart. 2016 Oct 1;102(19):1513-4. doi: 10.1136/heartjnl-2016-309761. Epub 2016 Jun 22.
6
Ablation of Atrial Fibrillation in Hypertrophic Cardiomyopathy: Semper Discere (Always Learning).
J Am Heart Assoc. 2021 Feb 2;10(3):e019876. doi: 10.1161/JAHA.120.019876. Epub 2021 Jan 17.
7
Atrial fibrillation and hypertrophic cardiomyopathy: More progress needed.
J Cardiovasc Electrophysiol. 2021 Mar;32(3):667-668. doi: 10.1111/jce.14874. Epub 2021 Jan 24.
8
Catheter ablation of atrial fibrillation in hypertrophic cardiomyopathy: long-term outcomes and mechanisms of arrhythmia recurrence.
Circ Arrhythm Electrophysiol. 2013 Dec;6(6):1089-94. doi: 10.1161/CIRCEP.113.000339. Epub 2013 Oct 10.
9
Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: Treatment Strategy, Characteristics of Consecutive Atrial Tachycardia and Long-Term Outcome.
J Am Heart Assoc. 2021 Feb 2;10(3):e017451. doi: 10.1161/JAHA.120.017451. Epub 2021 Jan 17.
10
Outcomes of nonpharmacologic treatment of atrial fibrillation in patients with hypertrophic cardiomyopathy.
Heart Rhythm. 2015 Jul;12(7):1438-47. doi: 10.1016/j.hrthm.2015.03.042. Epub 2015 Mar 23.
引用本文的文献
1
Atrial Cardiomyopathy: An Unexplored Limb of Virchow's Triad for AF Stroke Prophylaxis.
Front Cardiovasc Med. 2020 Feb 18;7:11. doi: 10.3389/fcvm.2020.00011. eCollection 2020.
本文引用的文献
1
The serum matrix metalloproteinase-9 level is an independent predictor of recurrence after ablation of persistent atrial fibrillation.
Clinics (Sao Paulo). 2016 May;71(5):251-6. doi: 10.6061/clinics/2016(05)02.
2
Primary Persistent Atrial Fibrillation: A Distinct Arrhythmia Subentity of an Ablation Population.
J Cardiovasc Electrophysiol. 2015 Dec;26(12):1289-94. doi: 10.1111/jce.12818. Epub 2015 Oct 12.
3
Approaches to catheter ablation for persistent atrial fibrillation.
N Engl J Med. 2015 May 7;372(19):1812-22. doi: 10.1056/NEJMoa1408288.
4
[Association of plasma fibronectin level with left atrial electrical and structural remodelling in lone paroxysmal atrial fibrillation: a cross-sectional study].
Turk Kardiyol Dern Ars. 2015 Apr;43(3):259-68. doi: 10.5543/tkda.2015.83893.
5
A prospective DE-MRI study evaluating the role of TGF-β1 in left atrial fibrosis and implications for outcomes of cryoballoon-based catheter ablation: new insights into primary fibrotic atriocardiomyopathy.
J Cardiovasc Electrophysiol. 2015 Mar;26(3):251-9. doi: 10.1111/jce.12578. Epub 2014 Dec 8.
6
Novel association between plasma matrix metalloproteinase-9 and risk of incident atrial fibrillation in a case-cohort study: the Atherosclerosis Risk in Communities study.
PLoS One. 2013;8(3):e59052. doi: 10.1371/journal.pone.0059052. Epub 2013 Mar 15.
7
Fibrotic atrial cardiomyopathy: a specific disease/syndrome supplying substrates for atrial fibrillation, atrial tachycardia, sinus node disease, AV node disease, and thromboembolic complications.
J Cardiovasc Electrophysiol. 2012 Jul;23(7):797-9. doi: 10.1111/j.1540-8167.2012.02341.x. Epub 2012 May 3.
8
Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation.
Circulation. 2009 Apr 7;119(13):1758-67. doi: 10.1161/CIRCULATIONAHA.108.811877. Epub 2009 Mar 23.
9
Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.
J Am Coll Cardiol. 2008 Feb 26;51(8):802-9. doi: 10.1016/j.jacc.2007.09.064.
10
Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease.
Heart. 2004 Apr;90(4):400-5. doi: 10.1136/hrt.2003.015347.
Zotero 插件